0001426581-12-000005.txt : 20120514
0001426581-12-000005.hdr.sgml : 20120514
20120514122802
ACCESSION NUMBER: 0001426581-12-000005
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120331
FILED AS OF DATE: 20120514
DATE AS OF CHANGE: 20120514
EFFECTIVENESS DATE: 20120514
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXPO CAPITAL MANAGEMENT LLC
CENTRAL INDEX KEY: 0001426581
IRS NUMBER: 208008350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-12799
FILM NUMBER: 12837442
BUSINESS ADDRESS:
STREET 1: 11111 SANTA MONICA BLVD
STREET 2: SUITE 1470
CITY: LOS ANGELES
STATE: CA
ZIP: 90025
BUSINESS PHONE: 310 201 7911
MAIL ADDRESS:
STREET 1: 11111 SANTA MONICA BLVD
STREET 2: SUITE 1470
CITY: LOS ANGELES
STATE: CA
ZIP: 90025
FORMER COMPANY:
FORMER CONFORMED NAME: EXPO CAPITAK MANAGEMENT LLC
DATE OF NAME CHANGE: 20080208
13F-HR
1
expo.txt
EXPO CAPITAL - FORM 13F - PE 03.31.12
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 13F
FORM 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: March 31, 2012
Check here if Amendment |_|;Amendment Number:_____
This Amendment (Check only one.): |_| is a restatement.
|_| adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Expo Capital Management, LLC
Address: 11111 Santa Monica Blvd.
Suite 1470
Los Angeles, CA 90025
13F File Number: 28-12799
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables, are considered integral parts of this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: Andrew Bzura
Title: Chief Operating Officer
Phone: 310-201-7911
Signature, Place, and Date of Signing:
/s/ Andrew Bzura Los Angeles, CA May 14, 2012
----------------------------------- ---------------- ------------------
[Signature] [City, State] [Date]
Report Type (Check only one.):
|X| 13F HOLDINGS REPORT. (Check here if all holdings of this reporting
manager are reported in this report.)
|_| 13F NOTICE. (Check here if no holdings reported are in this report, and
all holdings are reported by other reporting manager(s).)
|_| 13F COMBINATION REPORT. (Check here if a portion of the holdings for this
reporting manager are reported in this report and a portion are reported
by other reporting manager(s).)
FORM 13F
SUMMARY PAGE
Report Summary:
Number of Other Included Managers: 0
Form 13F Information Table Entry Total: 25
Form 13F Information Table Value Total: $523,782 (thousands)
List of Other Included Managers: None
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional investment managers with respect to which this report is filed,
other than the manager filing this report.
NONE
Expo Capital Management, LLC
March 31, 2012
FORM 13F INFORMATION TABLE
TITLE OF VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER CLASS CUSIP (x$1000)PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE
------------------------------------------------------------------------------------------------------------------------------
ALERE INC COM 01449J105 $18,857 725,000 SH Sole 725,000
ALLERGAN INC COM 018490102 $19,086 200,000 SH Sole 200,000
BROOKDALE SENIOR LIVING INC COM 112463104 $21,528 1,150,000 SH Sole 1,150,000
CENTENE CORP DEL COM 15135B101 $24,485 500,000 SH Sole 500,000
CEPHEID INC COM 15670R107 $21,961 525,000 SH Sole 525,000
CUBIST PHARMACEUTICALS INC COM 229678107 $20,544 475,000 SH Sole 475,000
ENDO PHARMACEUTICALS INC COM 29264F205 $27,111 700,000 SH Sole 700,000
GEN PROBE INC COM 36866T103 $18,263 275,000 SH Sole 275,000
HOLOGIC INC COM 436440101 $19,934 925,000 SH Sole 925,000
MEDICIS PHARMACEUTICAL CORP COM 584690309 $36,086 960,000 SH Sole 960,000
MOLINA HEALTHCARE INC COM 60855R100 $19,337 575,000 SH Sole 575,000
ONYX PHARMACEUTICALS INC COM 683399109 $20,724 550,000 SH Sole 550,000
PERKINELMER INC COM 714046109 $17,979 650,000 SH Sole 650,000
PSS WORLD MEDICAL INC COM 69366A100 $17,738 700,000 SH Sole 700,000
QIAGEN NV EUR COM N72482107 $21,020 1,350,000 SH Sole 1,350,000
SALIX PHARMACEUTICALS LTD COM 795435106 $18,375 350,000 SH Sole 350,000
SIRONA DENTAL SYSTEMS INC COM 82966C103 $23,193 450,000 SH Sole 450,000
THORATEC CORP COM 885175307 $19,383 575,000 SH Sole 575,000
UNITED THERAPEUTICS CORP COM 91307C102 $17,674 375,000 SH Sole 375,000
VCA ANTECH INC COM 918194101 $18,568 800,000 SH Sole 800,000
VOLCANO CORP COM 928645100 $26,252 925,000 SH Sole 925,000
WARNER CHILCOTT PLC COM G94368100 $18,491 1,100,000 SH Sole 1,100,000
WATERS CORP COM 941848103 $15,752 170,000 SH Sole 170,000
WATSON PHARMACEUTICALS INC COM 942683103 $23,471 350,000 SH Sole 350,000
WELLCARE HEALTH PLANS INC COM 94946T106 $17,970 250,000 SH Sole 250,000